Group One Trading’s Kindred Biosciences, Inc. KIN Stock Holding History

Group One Trading’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-30,976	Closed	-$284K	–	9108
2021 Q2	$284K	Buy	30,976 +1,052	+4%	+$6.12K	﹤0.01%	4842
2021 Q1	$149K	Buy	+29,924	New	+$145K	﹤0.01%	5290
2019 Q4	–	Sell	-4,800	Closed	-$37.5K	–	5844
2019 Q3	$33K	Hold	4,800	–	–	﹤0.01%	4177
2019 Q2	$40K	Buy	+4,800	New	+$41.4K	﹤0.01%	3892
2018 Q3	–	Sell	-100	Closed	-$1K	–	5809
2018 Q2	$1K	Sell	100 -10,203	-99%	-$99.5K	﹤0.01%	5012
2018 Q1	$89K	Sell	10,303 -19,100	-65%	-$168K	﹤0.01%	3319
2017 Q4	$278K	Buy	+29,403	New	+$230K	﹤0.01%	2701
2017 Q3	–	Sell	-10,003	Closed	-$75.1K	–	5340
2017 Q2	$86K	Buy	10,003 +2,300	+30%	+$16.5K	﹤0.01%	3203
2017 Q1	$54K	Buy	+7,703	New	+$48.3K	﹤0.01%	3359
2015 Q1	–	Sell	-101	Closed	-$1K	–	5370
2014 Q4	$1K	Buy	+101	New	+$857	﹤0.01%	4805

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Group One Trading's KIN Position: Q3 2021 in Review

Group One Trading sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 30,976 shares — an estimated $284K sold.

Group One Trading first reported a position in KIN in Q4 2014 and held it in 10 quarters. The position peaked at $284K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Group One Trading reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Group One Trading sold 30,976 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $284K.
Group One Trading first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 10 quarters.
Group One Trading's Kindred Biosciences, Inc. position peaked at $284K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.